Rubius Therapeutics, Inc. Current Ratio 2018-2022 | RUBY
Rubius Therapeutics, Inc. current ratio from 2018 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2022-12-31 |
$0.02B |
$0.01B |
2.54 |
2022-09-30 |
$0.11B |
$0.03B |
3.40 |
2022-06-30 |
$0.14B |
$0.03B |
4.63 |
2022-03-31 |
$0.18B |
$0.03B |
6.23 |
2021-12-31 |
$0.23B |
$0.04B |
6.63 |
2021-09-30 |
$0.27B |
$0.03B |
8.74 |
2021-06-30 |
$0.30B |
$0.03B |
12.12 |
2021-03-31 |
$0.34B |
$0.03B |
10.96 |
2020-12-31 |
$0.18B |
$0.03B |
6.52 |
2020-09-30 |
$0.21B |
$0.03B |
7.15 |
2020-06-30 |
$0.24B |
$0.03B |
8.44 |
2020-03-31 |
$0.25B |
$0.03B |
8.99 |
2019-12-31 |
$0.29B |
$0.03B |
8.57 |
2019-09-30 |
$0.33B |
$0.03B |
9.83 |
2019-06-30 |
$0.37B |
$0.02B |
17.27 |
2019-03-31 |
$0.39B |
$0.02B |
18.64 |
2018-12-31 |
$0.41B |
$0.02B |
20.72 |
2018-09-30 |
$0.41B |
$0.02B |
25.77 |
2018-06-30 |
$0.18B |
$0.02B |
12.26 |
2018-03-31 |
$0.00B |
|
0.00 |
2017-09-30 |
$0.00B |
|
0.00 |
2017-06-30 |
$0.00B |
|
0.00 |